ClinicalTrials.Veeva

Menu

Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors

P

Peking University

Status

Enrolling

Conditions

Spinal Tumor
Bone Tumor

Treatments

Diagnostic Test: Chemical shift encoding-based water-fat MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05631002
M2022403

Details and patient eligibility

About

Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.

Full description

Chemical shift encoding-based water-fat magnetic resonance imaging (MRI) is a non-invasive method that provides quantitative information about the biochemical water-fat composition of bone marrow and skeletal muscle in vivo.

Enrollment

150 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pathological biopsy of a patient with diagnosed spinal tumor lesion, and preoperative examination Chemical shift encoding-based water-fat MRI was performed.

Exclusion criteria

  • Recurrent neoplasms; Lesion diameter < 1 cm; Poor image quality.

Trial design

150 participants in 3 patient groups

Patients with benign spinal tumor
Treatment:
Diagnostic Test: Chemical shift encoding-based water-fat MRI
Patients with intermediate spinal tumor
Treatment:
Diagnostic Test: Chemical shift encoding-based water-fat MRI
Patients with malignant spinal tumor
Treatment:
Diagnostic Test: Chemical shift encoding-based water-fat MRI

Trial contacts and locations

1

Loading...

Central trial contact

Qizheng Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems